• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪细胞膜中胰抑制素受体及信号传导的特性研究

Characterization of pancreastatin receptors and signaling in adipocyte membranes.

作者信息

González-Yanes C, Santos-Alvarez J, Sánchez-Margalet V

机构信息

Departamento de Bioquímica Médica y Biología Molecular, Facultad de Medicina, Unidad de Investigación del Hospital Universitario Virgen Macarena, Av. Sánchez Pizjuan 4, Sevilla 41009, Spain.

出版信息

Biochim Biophys Acta. 1999 Aug 12;1451(1):153-62. doi: 10.1016/s0167-4889(99)00084-1.

DOI:10.1016/s0167-4889(99)00084-1
PMID:10446397
Abstract

Pancreastatin (PST), a chromogranin A derived peptide with an array of effects in different tissues, has a role as a counterregulatory hormone of insulin action in hepatocytes and adipocytes, regulating glucose, lipid and protein metabolism. We have previously characterized PST receptors and signaling in rat hepatocytes, in which PST functions as a calcium-mobilizing hormone. In the present work we have studied PST receptors as well as the signal transduction pathways generated upon PST binding in adipocyte membranes. First, we have characterized PST receptors using radiolabeled PST as a ligand. Analysis of binding data indicated the existence of one class of binding sites, with a B(max) of 5 fmol/mg of protein and a K(d) of 1 nM. In addition, we have studied the G protein system that couples the PST receptor by gamma-(35)S-GTP binding studies. We have found that two G protein systems are involved, pertussis toxin-sensitive and -insensitive respectively. Specific anti-G protein alpha subtype sera were used to block the effect of pancreastatin receptor activation. Galpha(q/11) and to a lesser extent Galpha(i1,2) are activated by PST in rat adipocyte membranes. On the other hand, adenylate cyclase activity was not affected by PST. Finally, we have studied the specific phospholipase C isoform that is activated in response to PST. We have found that PST receptor is coupled to PLC-beta(3) via Galpha(q/11) activation in adipocyte membranes.

摘要

胰抑制素(PST)是一种源自嗜铬粒蛋白A的肽,在不同组织中具有一系列作用,它作为肝细胞和脂肪细胞中胰岛素作用的反调节激素,调节葡萄糖、脂质和蛋白质代谢。我们之前已对大鼠肝细胞中的PST受体和信号传导进行了表征,在这些细胞中PST作为一种钙动员激素发挥作用。在本研究中,我们研究了脂肪细胞膜中PST受体以及PST结合后产生的信号转导途径。首先,我们使用放射性标记的PST作为配体对PST受体进行了表征。结合数据分析表明存在一类结合位点,其B(max)为5 fmol/mg蛋白质,K(d)为1 nM。此外,我们通过γ-(35)S-GTP结合研究对与PST受体偶联的G蛋白系统进行了研究。我们发现涉及两个G蛋白系统,分别对百日咳毒素敏感和不敏感。使用特异性抗G蛋白α亚型血清来阻断胰抑制素受体激活的作用。在大鼠脂肪细胞膜中,Gα(q/11)以及程度较轻的Gα(i1,2)被PST激活。另一方面,腺苷酸环化酶活性不受PST影响。最后,我们研究了响应PST而被激活的特异性磷脂酶C同工型。我们发现,在脂肪细胞膜中,PST受体通过Gα(q/11)激活与PLC-β(3)偶联。

相似文献

1
Characterization of pancreastatin receptors and signaling in adipocyte membranes.脂肪细胞膜中胰抑制素受体及信号传导的特性研究
Biochim Biophys Acta. 1999 Aug 12;1451(1):153-62. doi: 10.1016/s0167-4889(99)00084-1.
2
Pancreastatin activates pertussis toxin-sensitive guanylate cyclase and pertussis toxin-insensitive phospholipase C in rat liver membranes.胰抑制素激活大鼠肝细胞膜中对百日咳毒素敏感的鸟苷酸环化酶和对百日咳毒素不敏感的磷脂酶C。
J Cell Biochem. 1994 Jun;55(2):173-81. doi: 10.1002/jcb.240550204.
3
Pancreastatin receptor is coupled to a guanosine triphosphate-binding protein of the G(q/11)alpha family in rat liver membranes.
Hepatology. 1998 Feb;27(2):608-14. doi: 10.1002/hep.510270240.
4
Pancreastatin, a chromogranin A-derived peptide, activates Galpha(16) and phospholipase C-beta(2) by interacting with specific receptors in rat heart membranes.胰抑制素是一种源自嗜铬粒蛋白A的肽,它通过与大鼠心脏膜中的特定受体相互作用来激活Gα(16)和磷脂酶C-β(2)。
Cell Signal. 2001 Jan;13(1):43-9. doi: 10.1016/s0898-6568(00)00127-3.
5
G protein G alpha q/11 and G alpha i1,2 are activated by pancreastatin receptors in rat liver: studies with GTP-gamma 35S and azido-GTP-alpha-32P.G蛋白Gαq/11和Gαi1,2可被大鼠肝脏中的胰抑制素受体激活:利用GTP-γ35S和叠氮基-GTP-α-32P进行的研究。
J Cell Biochem. 1999 Jun 15;73(4):469-77. doi: 10.1002/(sici)1097-4644(19990615)73:4<469::aid-jcb5>3.0.co;2-u.
6
Pancreastatin activates beta3 isoform of phospholipase C via G(alpha)11 protein stimulation in rat liver membranes.
Mol Cell Endocrinol. 1998 Aug 25;143(1-2):101-6. doi: 10.1016/s0303-7207(98)00137-3.
7
Characterization of pancreastatin receptor and signaling in rat HTC hepatoma cells.
Eur J Pharmacol. 2000 Jun 2;397(2-3):229-35. doi: 10.1016/s0014-2999(00)00253-3.
8
Smooth muscle adenosine A1 receptors couple to disparate effectors by distinct G proteins in pregnant myometrium.在妊娠子宫肌层中,平滑肌腺苷A1受体通过不同的G蛋白与不同的效应器偶联。
Am J Physiol. 1991 Jul;261(1 Pt 1):E141-50. doi: 10.1152/ajpendo.1991.261.1.E141.
9
Pancreastatin, a chromogranin A-derived peptide, activates protein synthesis signaling cascade in rat adipocytes.胰抑素是一种源自嗜铬粒蛋白A的肽,可激活大鼠脂肪细胞中的蛋白质合成信号级联反应。
Biochem Biophys Res Commun. 2002 Dec 13;299(4):525-31. doi: 10.1016/s0006-291x(02)02682-7.
10
Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk.胰抑制素调节大鼠脂肪细胞中的胰岛素信号传导:相互作用机制
Diabetes. 2000 Aug;49(8):1288-94. doi: 10.2337/diabetes.49.8.1288.

引用本文的文献

1
The immunomodulatory functions of chromogranin A-derived peptide pancreastatin.嗜铬粒蛋白 A 衍生肽胰淀素的免疫调节功能。
Peptides. 2022 Dec;158:170893. doi: 10.1016/j.peptides.2022.170893. Epub 2022 Oct 13.
2
Discovery of a novel target for the dysglycemic chromogranin A fragment pancreastatin: interaction with the chaperone GRP78 to influence metabolism.血糖异常的嗜铬粒蛋白A片段胰腺抑素的新靶点发现:与伴侣蛋白GRP78相互作用以影响代谢
PLoS One. 2014 Jan 20;9(1):e84132. doi: 10.1371/journal.pone.0084132. eCollection 2014.
3
A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis.
嗜铬粒蛋白A基因敲除小鼠中胰岛素敏感性的新途径:胰腺抑制素在葡萄糖稳态中的关键作用。
J Biol Chem. 2009 Oct 16;284(42):28498-509. doi: 10.1074/jbc.M109.020636. Epub 2009 Aug 25.
4
The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.嗜铬粒蛋白:它们在神经内分泌细胞分泌中的作用以及作为神经内分泌肿瘤标志物的作用。
Endocr Pathol. 2003 Spring;14(1):3-23. doi: 10.1385/ep:14:1:3.